WCN25-1675 ANTI-NEPHRIN ANTIBODIES IN ADULT CHINESE PATIENTS WITH MINIMAL CHANGE DISEASE AND PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS

WCN25-1675 ANTI-NEPHRIN ANTIBODIES IN ADULT CHINESE PATIENTS WITH MINIMAL CHANGE DISEASE AND PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS

Saved in:

Bibliographic Details
Main Authors:	Yue Shu, Jing Huang, Lei Jiang, Yi-miao Zhang, Fang Wang, Xin Wang, Li-qiang Meng, Xu-yang Cheng, Gang Liu, Su-xia Wang, Ming-hui Zhao, Zhao Cui
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924024070
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-2015 EFFICACY OF RITUXIMAB IN MINIMAL CHANGE DISEASE AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS : A SINGLE CENTRE EXPERIENCE FROM INDIA
by: Harshkumar Patel, et al.
Published: (2025-02-01)

WCN25-63 Refractory Nephrotic Syndrome in Focal and Segmental Glomerulosclerosis by PMM2 Genetic Variant
by: Jaime Arturo Dulce M, et al.
Published: (2025-02-01)

WCN24-1899 RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN KIDNEY TRANSPLANTATION
by: Adriana M. Lituma, et al.
Published: (2024-04-01)

Familial focal segmental glomerulosclerosis in infancy
by: A Bakkaloğlu, et al.
Published: (1988-01-01)

WCN25-3085 MOLECULAR ALTERATIONS OF PODOCYTES IN PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND IMMUNOGLOBULIN A NEPHROPATHY: AN EXPLORATORY STUDY
by: Natalia Semenova, et al.
Published: (2025-02-01)

WCN25-3115 MOLECULAR ALTERATIONS OF PODOCYTES IN PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND IMMUNOGLOBULIN A NEPHROPATHY: AN EXPLORATORY STUDY
by: Vladimir Dobronravov, et al.
Published: (2025-02-01)

RESOLVE: Recurrence Posttransplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
by: Eloise C. Salmon, et al.
Published: (2024-12-01)

Pathogenesis of Focal Segmental Glomerulosclerosis and Minimal Change Disease: Insights from Glomerular Proteomics
by: Yuriy Maslyennikov, et al.
Published: (2025-03-01)

WCN24-29 SPONTANEOUS REMISSION OF POST TRANSPLANT RECURRENT FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS
by: Mohamad Bassam Said
Published: (2024-04-01)

Focal segmental glomerulosclerosis: current status of the problem
by: I. T. Murkamilov, et al.
Published: (2020-01-01)

The Novel Diagnostic Biomarkers for Focal Segmental Glomerulosclerosis
by: Mohsen Nafar, et al.
Published: (2014-01-01)

WCN25-3004 ANTi-NEPHRIN ANTIBODIES IN A LARGE COHORT OF PATIENTS WITH IDIOPATHIC NEPHROTIC SYNDROME
by: Andrea Angeletti, et al.
Published: (2025-02-01)

WCN25-2195 CLINICAL COURSE AND OUTCOME OF ADULT PATIENTS WITH PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH KIDNEY FUNCTION LOSS ON PRESENTATION
by: Nazarul Hassan Jafry, et al.
Published: (2025-02-01)

WCN25-3905 TMEM30A downregulation initiate podocyte injury through reducing glycolysis in focal segmental glomerulosclerosis
by: LI GUISEN
Published: (2025-02-01)

WCN25-2069 RENAL-LOSS HYPOKALEMIA COMPLICATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS PRESENTING AS NEPHROTIC SYNDROME: A RARE CASE
by: Calvin Kurnia Mulyadi, et al.
Published: (2025-02-01)

WCN25-1081 STUDY OF CLINICAL SIGNIFICANCE OF IgM AND C3 GLOMERULAR DEPOSITIS IN PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS
by: Prajit mazumdar, et al.
Published: (2025-02-01)

Value of urinary CD80 in differentiating minimal change disease from focal segmental glomerulosclerosis
by: Phuong Anh Le-Thy, et al.
Published: (2024-06-01)

Is the Prevalence of Focal and Segmental Glomerulosclerosis Increasing in the Province of Khuzestan?
by: Seyed Seifollah Beladi Mousavi, et al.
Published: (2012-05-01)

A Prospective Study on Complement Activation Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease
by: Alexandra Cambier, et al.
Published: (2024-03-01)

WCN24-2707 Focal and Segmental Glomerulosclerosis and Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a Case Report
by: Katia Olga Teresa Hernández Torres, et al.
Published: (2024-04-01)

Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis
by: Wee Leng Gan, et al.
Published: (2018-10-01)

Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis
by: Wee Leng Gan, et al.
Published: (2018-10-01)

WCN24-1921 NEPHROTIC SYNDROME SECONDARY AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS DUE TO PODOCYTE KANK-2 MUTATION
by: Sandra Liliana Borda Galindo, et al.
Published: (2024-04-01)

WCN25-907 CLINICAL CHARACTERISTICS IN CHILDREN WITH MONOGENIC AND NON-GENETIC STEROID-RESISTANT NEPHROTIC SYNDROME DUE TO FOCAL SEGMENTAL GLOMERULOSCLEROSIS TREATED WITH CALCINEURIN INHIBITORS
by: Larisa Prikhodina
Published: (2025-02-01)

Antinephrin-Associated Primary Focal Segmental Glomerulosclerosis Successfully Treated With Plasmapheresis
by: Iain Bressendorff, et al.
Published: (2024-09-01)

Unraveling the Role of Complement in Focal Segmental Glomerulosclerosis Pathogenesis: Insights and Challenges
by: Alexandra Cambier, et al.
Published: (2024-06-01)

From Gene to Clinic: The Role of APOL1 in Focal Segmental Glomerulosclerosis
by: Charlotte Delrue, et al.
Published: (2025-02-01)

WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS)
by: Jonathon Barratt, et al.
Published: (2024-04-01)

Comparison and prognostic analysis of focal segmental glomerulosclerosis patients with or without nephrotic syndrome at onset
by: Liangliang Chen, et al.
Published: (2025-07-01)

A polymeric dexamethasone prodrug attenuates focal segmental glomerulosclerosis (FSGS) in an Adriamycin-induced mouse model with minimal glucocorticoid side effects
by: Haochen Jiang, et al.
Published: (2025-03-01)

WCN24-281 A STUDY ON THE FACTORS AFFECTING OUTCOMES OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND THE IMPORTANCE OF GENETIC DIAGNOSTICS IN PREDICTING OUTCOMES
by: KAJAREE GIRI, et al.
Published: (2024-04-01)

Incidence and risk factors for recurrent focal segmental glomerulosclerosis after kidney transplantation: a meta-analysis
by: Jiang Bai, et al.
Published: (2023-12-01)

Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design
by: Lisa Daniel-Fischer, et al.
Published: (2024-02-01)

Infections, Immunosuppressants, and Focal Segmental Glomerulosclerosis Transplants: A Never-ending Challenge
by: Arjun Agarwal, et al.
Published: (2025-01-01)

Recurrent Focal Segmental Glomerulosclerosis after Kidney Transplantation: Challenges and Evolving Strategies
by: S. Sabarinath, et al.
Published: (2025-01-01)

Assessment of podocyte detachment as a pivotal step in the development of focal segmental glomerulosclerosis
by: Ikbal Ahmed Abdo Elkholy, et al.
Published: (2024-11-01)

Controlling proteinuria in secondary focal segmental glomerulosclerosis with cyclosporine: A case report
by: Sohrab Kharabaf, et al.
Published: (2025-07-01)

Early Focal Segmental Glomerulosclerosis as a Cause of Renal Allograft Primary Nonfunction
by: Emma J. Griffin, et al.
Published: (2013-01-01)

ECHS1 as a Lipid Metabolism Biomarker for Pediatric Focal Segmental Glomerulosclerosis.
by: Chao He, et al.
Published: (2025-01-01)

Podocyte specific knockout of the natriuretic peptide clearance receptor is podocyte protective in focal segmental glomerulosclerosis.
by: Liming Wang, et al.
Published: (2025-01-01)